Skip to main content

Table 3 Comparison of Hazard Ratio of all-cause and cardiovascular mortality

From: The combination of nonthyroidal illness syndrome and renal dysfunction further increases mortality risk in patients with acute myocardial infarction: a prospective cohort study

  Normal Group NTIS Group Renal dysfunction Group Combined Group
HR (95% CI) HR 95% CI P value HR 95% CI P value HR 95% CI P value
All-cause mortality
 Model 1 1 1.912 1.219–2.998 0.005 1.514 1.056–2.170 0.024 3.209 2.157–4.774 < 0.001
 Model 2 1 2.036 1.252–3.312 0.004 1.675 1.090–2.572 0.019 3.488 2.223–5.471 < 0.001
 Model 3 1 2.138 1.234–3.704 0.007 2.050 1.271–3.307 0.003 4.140 2.534–6.764 < 0.001
Cardiovascular mortality
 Model 1 1 1.903 1.010–3.587 0.047 1.730 1.074–2.788 0.024 3.955 2.387–6.553 < 0.001
 Model 2 1 2.141 1.087–4.217 0.028 2.089 1.185–3.684 0.011 4.580 2.578–8.136 < 0.001
 Model 3 1 2.134 1.028–4.430 0.042 2.237 1.210–4.135 0.010 5.152 2.786–9.527 < 0.001
  1. Model1: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy (use of antiplatelet agents, β-Blockers, LLDs, ACEIs/ARBs, CCBs, and Diuretics), and BMI (for all patients)
  2. Model2: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy, BMI, LVEF, Killip class, lg(NT-pro BNP), infarct type (NSTEMI vs STEMI), prior PCI or CABG and revascularization (PCI, CABG) (for all patients)
  3. Model3: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy, BMI, LVEF, Killip class, lg(NT-pro BNP), infarct type (NSTEMI vs STEMI), prior PCI or CABG and revascularization (PCI, CABG), WBC, Hb, Alb, TC, TG, HDL-c, LDL-c, FPG and CRP (for all patients)